patents

Federal court rules Ampyra patents invalid, Acorda stock sinks 25%
Federal court rules Ampyra patents invalid, Acorda stock sinks 25%
Biopharma Dive
Acorda Therapeutics
MS
multiple sclerosis
AMPYRA
patents
Flag link:
Appeals court upholds CRISPR patents awarded to the Broad Institute
Appeals court upholds CRISPR patents awarded to the Broad Institute
Stat
CRISPR
patents
Broad Institute
University of California
Flag link:
[sponsored] Orange Book Companion® Adds New Features and Capabilities
[sponsored] Orange Book Companion® Adds New Features and Capabilities
CP Wire
patents
Hatch Waxman Act
FDA
exclusivity
Flag link:
[sponsored] Orange Book Companion® Adds New Features and Capabilities
patents
Hatch Waxman Act
FDA
exclusivity
Flag link:
Gleevec antitrust suits against Novartis, after failing initially, fall short again in appeals
Gleevec antitrust suits against Novartis, after failing initially, fall short again in appeals
Fierce Pharma
Novartis
Gleevec
patents
Flag link:
In Pharma Patent Disputes, Data Rules Over Intuition And (Gasp!) Legal Judgment
In Pharma Patent Disputes, Data Rules Over Intuition And (Gasp!) Legal Judgment
Forbes
patents
patent lawsuits
Flag link:
How Companies Protect Intellectual Property Involving Live Microbes - Interview With a Patent Attorney
How Companies Protect Intellectual Property Involving Live Microbes - Interview With a Patent Attorney
CP Wire
patents
microbiome
microbe
intellectual property
Flag link:
Microbiome Report for the week ending 7-29-18
Microbiome Report for the week ending 7-29-18
CP Wire
microbiome
Finch Therapeutics
patents
Qu Biologics
Crohn’s disease
Alzheimer's disease
Flag link:
Microbiome Report for the week ending 7-29-18
microbiome
Finch Therapeutics
patents
Qu Biologics
Crohn’s disease
Alzheimer's disease
Flag link:
Pfizer Wins Remicade Patent Case Over J&J
Pfizer Wins Remicade Patent Case Over J&J
RAPS.org
Pfizer
Celltrion
JNJ
Janssen
patents
Remicade
Flag link:
Omeros Prevails in Patent Dispute With Sandoz
Omeros Prevails in Patent Dispute With Sandoz
CP Wire
Omeros
Sandoz
Novartis
patents
Omidria
Flag link:
On top of expiring Herceptin patents, Roche faces huge royalty losses in 2019
On top of expiring Herceptin patents, Roche faces huge royalty losses in 2019
Endpoints
Roche
patents
Herceptin
Cabilly patents
Flag link:
Finch Therapeutics Expands Microbiome IP Portfolio with Six New Patents
Finch Therapeutics Expands Microbiome IP Portfolio with Six New Patents
CP Wire
Finch Therapeutics
microbiome
patents
Flag link:
Federal judges ban Allergan’s sovereign immunity scheme in a slapdown that will bolster inter partes review for years to come
Federal judges ban Allergan’s sovereign immunity scheme in a slapdown that will bolster inter partes review for years to come
Endpoints
Allergan
patents
Restasis
inter partes review
Flag link:
Novartis' MS patent win also a win for Celgene's impending MS drug: analyst
Novartis' MS patent win also a win for Celgene's impending MS drug: analyst
Medical Marketing and Media
Celgene
Novartis
ozanimod
Gilenya
MS
multiple sclerosis
patents
Flag link:
MS patent win boosts Novartis’ Gilenya, helps Celgene and maybe Biogen too
MS patent win boosts Novartis’ Gilenya, helps Celgene and maybe Biogen too
Fierce Pharma
patents
Novartis
MS
Gilenya
Celgene
exclusivity
Flag link:
Eagle Pharmaceuticals Receives New Patent for Bendeka Configure
Eagle Pharmaceuticals Receives New Patent for Bendeka Configure
CP Wire
Eagle Pharmaceuticals
Bendeka
Teva Pharmaceuticals
CLL
patents
Flag link:
AI Will Not Threaten Pharma Patents – Not This Way
AI Will Not Threaten Pharma Patents – Not This Way
Science Translational Medicine
artificial intelligence
drug discovery
patents
Flag link:
Allergan: This $64,000 Question Could Kill Restasis IPR Appeal
Allergan: This $64,000 Question Could Kill Restasis IPR Appeal
NY Shock Exchange
Allergan
Restasis
IPR
patents
Flag link:
FDA Updates List of Drugs Without Generic Competition
FDA Updates List of Drugs Without Generic Competition
RAPS.org
FDA
generics
patents
Flag link:

Pages